{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:44:52Z","timestamp":1740109492670,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-093","2022-PUMCH-B-033"],"award-info":[{"award-number":["2022-PUMCH-A-093","2022-PUMCH-B-033"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2703100"],"award-info":[{"award-number":["2022YFC2703100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00216-023-04964-5","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:27:34Z","timestamp":1695958054000},"page":"6863-6871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a rapid simultaneous assay of two urinary tetrasaccharide metabolites using differential ion mobility and tandem mass spectrometry and its application to patients with glycogen storage disease (type Ib and II)"],"prefix":"10.1007","volume":"415","author":[{"given":"Jianwei","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingsheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-0167","authenticated-orcid":false,"given":"Xiaohong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"R1","key":"4964_CR1","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1093\/hmg\/ddz133","volume":"28","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Sun B, Koeberl DD. Gene therapy for glycogen storage diseases. Hum Mol Genet. 2019;28(R1):R31\u201341. https:\/\/doi.org\/10.1093\/hmg\/ddz133.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4964_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6(1):27. https:\/\/doi.org\/10.1186\/1750-1172-6-27.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"4964_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11940-022-00736-1","volume":"24","author":"D Stevens","year":"2022","unstructured":"Stevens D, Milani-Nejad S, Mozaffar T. Pompe disease: a clinical, diagnostic, and therapeutic overview. Curr Treat Options Neurol. 2022;24(11):573\u201388. https:\/\/doi.org\/10.1007\/s11940-022-00736-1.","journal-title":"Curr Treat Options Neurol"},{"issue":"6","key":"4964_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mus.880160614","volume":"16","author":"RJ Barohn","year":"1993","unstructured":"Barohn RJ, McVey AL, Dimauro S, Griggs RC, Mendell JR, Miller RG. Adult acid maltase deficiency. Muscle Nerve. 1993;16(6):672\u20136. https:\/\/doi.org\/10.1002\/mus.880160614.","journal-title":"Muscle Nerve"},{"issue":"3","key":"4964_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/brain\/93.3.599","volume":"93","author":"AG Engel","year":"1970","unstructured":"Engel AG. Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain. 1970;93(3):599\u2013616. https:\/\/doi.org\/10.1093\/brain\/93.3.599.","journal-title":"Brain"},{"issue":"3","key":"4964_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","volume":"120","author":"J Chan","year":"2017","unstructured":"Chan J, Desai AK, Kazi ZB, Corey K, Austin S, Hobson-Webb LD, et al. The emerging phenotype of late-onset Pompe disease: a systematic literature review. Mol Genet Metab. 2017;120(3):163\u201372. https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.004.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"4964_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ymgme.2018.08.009","volume":"126","author":"M Herbert","year":"2019","unstructured":"Herbert M, Case LE, Rairikar M, Cope H, Bailey L, Austin SL, et al. Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32\u201313 T > G variant. Mol Genet Metab. 2019;126(2):106\u201316. https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.009.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4964_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8(5):267\u201388. https:\/\/doi.org\/10.1097\/01.gim.0000218152.87434.f3.","journal-title":"Genet Med"},{"issue":"5","key":"4964_CR9","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JM Van den Hout","year":"2004","unstructured":"Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004;113(5):e448\u201357. https:\/\/doi.org\/10.1542\/peds.113.5.e448.","journal-title":"Pediatrics"},{"key":"4964_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JND-190426","volume":"7","author":"SM Salabarria","year":"2020","unstructured":"Salabarria SM, Nair J, Clement N, Smith BK, Raben N, Fuller DD, et al. Advancements in AAV-mediated gene therapy for Pompe disease. J Neuromuscul Dis. 2020;7:15\u201331. https:\/\/doi.org\/10.3233\/JND-190426.","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"4964_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2362.1974.tb00416.x","volume":"4","author":"P Hallgren","year":"1974","unstructured":"Hallgren P, Hansson G, Henriksson KG, H\u00e4ger A, Lundblad A, Svensson S. Increased excretion of a glucose-containing tetrasaccharide in the urine of a patient with glycogen storage disease type II (Pompe\u2019s disease). Eur J Clin Invest. 1974;4(6):429\u201333. https:\/\/doi.org\/10.1111\/j.1365-2362.1974.tb00416.x.","journal-title":"Eur J Clin Invest"},{"issue":"8331","key":"4964_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/s0140-6736(83)92122-0","volume":"1","author":"MA Chester","year":"1983","unstructured":"Chester MA, Lundblad A, H\u00e4ger A, Sj\u00f6blad S, Loonen C, Tager JM, et al. Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III. Lancet. 1983;1(8331):994\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(83)92122-0.","journal-title":"Lancet"},{"issue":"7","key":"4964_CR13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","volume":"58","author":"W Sluiter","year":"2012","unstructured":"Sluiter W, van den Bosch JC, Goudriaan DA, van Gelder CM, de Vries JM, Huijmans JGM, et al. Rapid ultraperformance liquid chromatography\u2013tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe Disease and other glycogen storage diseases. Clin Chem. 2012;58(7):1139\u201347. https:\/\/doi.org\/10.1373\/clinchem.2011.178319.","journal-title":"Clin Chem"},{"issue":"11","key":"4964_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/s41436-020-0878-2","volume":"22","author":"MR Heiner-Fokkema","year":"2020","unstructured":"Heiner-Fokkema MR, van der Krogt J, de Boer F, Fokkert-Wilts MJ, Maatman RGHJ, Hoogeveen IJ, et al. The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases. Genet Med. 2020;22(11):1915\u20136. https:\/\/doi.org\/10.1038\/s41436-020-0878-2.","journal-title":"Genet Med"},{"issue":"3","key":"4964_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ijtm1030023","volume":"1","author":"AK Murray","year":"2021","unstructured":"Murray AK. The action of recombinant human lysosomal & alpha-glucosidase (rhGAA) on human liver glycogen: pathway to complete degradation. Int J Transl Med. 2021;1(3):381\u2013402. https:\/\/doi.org\/10.3390\/ijtm1030023.","journal-title":"Int J Transl Med"},{"issue":"1","key":"4964_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/abio.2000.4838","volume":"287","author":"Y An","year":"2000","unstructured":"An Y, Young SP, Hillman SL, Van Hove JL, Chen YT, Millington DS. Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal Biochem. 2000;287(1):136\u201343. https:\/\/doi.org\/10.1006\/abio.2000.4838.","journal-title":"Anal Biochem"},{"issue":"1\u20132","key":"4964_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0009-8981(83)90200-0","volume":"134","author":"W Blom","year":"1983","unstructured":"Blom W, Luteyn JC, Kelholt-Dijkman HH, Huijmans JG, Loonen MC. Thin-layer chromatography of oligosaccharides in urine as a rapid indication for the diagnosis of lysosomal acid maltase deficiency (Pompe\u2019s disease). Clin Chim Acta. 1983;134(1\u20132):221\u20137. https:\/\/doi.org\/10.1016\/0009-8981(83)90200-0.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"4964_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10545-011-9360-2","volume":"35","author":"V Manwaring","year":"2012","unstructured":"Manwaring V, Prunty H, Bainbridge K, Burke D, Finnegan N, Franses R, et al. Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases. J Inherit Metab Dis. 2012;35(2):311\u20136. https:\/\/doi.org\/10.1007\/s10545-011-9360-2.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4964_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0003-2697(03)00056-3","volume":"316","author":"SP Young","year":"2003","unstructured":"Young SP, Stevens RD, An Y, Chen YT, Millington DS. Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry. Anal Biochem. 2003;316(2):175\u201380. https:\/\/doi.org\/10.1016\/s0003-2697(03)00056-3.","journal-title":"Anal Biochem"},{"issue":"7","key":"4964_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","volume":"11","author":"SP Young","year":"2009","unstructured":"Young SP, Zhang H, Corzo D, Thurberg BL, Bali D, Kishnani PS, et al. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med. 2009;11(7):536\u201341. https:\/\/doi.org\/10.1097\/GIM.0b013e3181a87867.","journal-title":"Genet Med"},{"issue":"15","key":"4964_CR21","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1021\/acs.analchem.9b01595","volume":"91","author":"CS Lane","year":"2019","unstructured":"Lane CS, McManus K, Widdowson P, Flowers SA, Powell G, Anderson I, et al. Separation of sialylated glycan isomers by differential mobility spectrometry. Anal Chem. 2019;91(15):9916\u201324. https:\/\/doi.org\/10.1021\/acs.analchem.9b01595.","journal-title":"Anal Chem"},{"issue":"11","key":"4964_CR22","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jms.3828","volume":"51","author":"DJ Harvey","year":"2016","unstructured":"Harvey DJ, Scarff CA, Edgeworth M, Pagel K, Thalassinos K, Struwe WB, et al. Travelling-wave ion mobility mass spectrometry and negative ion fragmentation of hybrid and complex N-glycans. J Mass Spectrom. 2016;51(11):1064\u201379. https:\/\/doi.org\/10.1002\/jms.3828.","journal-title":"J Mass Spectrom"},{"issue":"24","key":"4964_CR23","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1007\/s00216-019-01807-0","volume":"411","author":"AT Kirk","year":"2019","unstructured":"Kirk AT, Bohnhorst A, Raddatz C-R, Allers M, Zimmermann S. Ultra-high-resolution ion mobility spectrometry\u2014current instrumentation, limitations, and future developments. Anal Bioanal Chem. 2019;411(24):6229\u201346. https:\/\/doi.org\/10.1007\/s00216-019-01807-0.","journal-title":"Anal Bioanal Chem"},{"key":"4964_CR24","doi-asserted-by":"publisher","first-page":"104526","DOI":"10.1016\/j.yexmp.2020.104526","volume":"117","author":"A Kontunen","year":"2020","unstructured":"Kontunen A, Tuominen J, Karjalainen M, Anttalainen O, Tolonen T, Kumpulainen P, et al. Differential mobility spectrometry imaging for pathological applications. Exp Mol Pathol. 2020;117:104526. https:\/\/doi.org\/10.1016\/j.yexmp.2020.104526.","journal-title":"Exp Mol Pathol."},{"issue":"1","key":"4964_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1373\/clinchem.2015.238626","volume":"62","author":"KL Lynch","year":"2016","unstructured":"Lynch KL. CLSI C62-A: a new standard for clinical mass spectrometry. Clin Chem. 2016;62(1):24\u20139. https:\/\/doi.org\/10.1373\/clinchem.2015.238626.","journal-title":"Clin Chem"},{"key":"4964_CR26","unstructured":"U. S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Veterinary Medicine (CMV). Guidance for Industry: Bioanalytical Method Validation; Food and Drug Administration. 2018. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. Accessed 15 Jun 2023."},{"issue":"9","key":"4964_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jat\/bky042","volume":"42","author":"M Dziadosz","year":"2018","unstructured":"Dziadosz M. Adduct formation-supported two-way electrospray ionization strategy for the determination of urinary creatinine concentration with LC\u2013MS-MS in abstinence control. J Anal Toxicol. 2018;42(9):625\u20139. https:\/\/doi.org\/10.1093\/jat\/bky042.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"4964_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","volume":"85","author":"Y An","year":"2005","unstructured":"An Y, Young SP, Kishnani PS, Millington DS, Amalfitano A, Corzo D, et al. Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. Mol Genet Metab. 2005;85(4):247\u201354. https:\/\/doi.org\/10.1016\/j.ymgme.2005.03.010.","journal-title":"Mol Genet Metab"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-023-04964-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T02:05:22Z","timestamp":1698199522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-023-04964-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":28,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4964"],"URL":"https:\/\/doi.org\/10.1007\/s00216-023-04964-5","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"type":"print","value":"1618-2642"},{"type":"electronic","value":"1618-2650"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Peking Union Medical College Hospital Ethics Committee (I-22PJ394).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}